Bruce Tripp, MD
Radiation Oncology · Brunswick, GANPI 1982661641
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.1% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 25.0% of the total. Reporting peaked in 2024 at $173 and has fallen 65.6% since, to $60 in 2025. That places this record below the midpoint for radiation oncology clinicians in GA, where the typical reported total is $527.
Across 19 payments — averaging $25.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$123
- Takeda Pharmaceuticals U.S.A., Inc.$105
- Novartis$48
- Myovant Sciences Inc.$39
- Merck$37
- Tersera Therapeutics LLC$31
- plus $108 from 5 others
What the payments were for
- Food & beverage$46795%
- Education$245%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $105 |
| Novartis | 2 | $48 |
| Myovant Sciences Inc. | 2 | $39 |
| Merck | 2 | $37 |
| Tersera Therapeutics LLC | 1 | $31 |
| Jazz Pharmaceuticals Inc. | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $25 |
| AstraZeneca | 1 | $22 |
| Sanofi | 1 | $18 |
| Novocure Inc. | 1 | $16 |
How this compares
$491 in reported general payments places this provider in the 45th percentile of 165 radiation oncology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine Hcl ViscousLidocaine Hcl | 20 | $473 |
| Tamsulosin Hcl | 17 | $159 |
| Fluconazole | 11 | $113 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Brunswick
- Kristin HigginsAtlanta$230K
- Walter CurranAtlanta$83K
- Ian CrockerAtlanta$51K
- Sagar PatelAtlanta$32K
- Hui-Kuo ShuAtlanta$25K
- Wilfred WilliamsAtlanta$15K
- Nancy WiggersAtlanta$11K
- Adam NowlanAtlanta$11K
- Ashesh JaniAtlanta$10K
- Mark McLaughlinMarietta$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.